AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2016 to Q4 2025

Type / Class
Equity / Common Stock - $0.01 Par Value
Symbol
AVNS on NYSE
Shares outstanding
46,382,189
Price per share
$11.23
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
44,941,404
Total reported value
$519,510,585
% of total 13F portfolios
0%
Share change
+177,440
Value change
-$417,911
Number of holders
268
Price from insider filings
$11.23
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $84,305,460 6,826,353 BlackRock, Inc. 31 Mar 2025
T. Rowe Price Investment Management, Inc. 10% +25% $54,487,048 +$11,050,221 4,713,494 +25% T. Rowe Price Investment Management, Inc. 30 Sep 2025
VANGUARD GROUP INC 7.4% -23% $39,595,474 -$12,018,724 3,425,214 -23% The Vanguard Group 30 Sep 2025
RGM Capital, LLC 6.5% $36,883,510 2,986,519 RGM Capital, LLC 31 Dec 2024
ARMISTICE CAPITAL, LLC 5.4% $28,900,000 2,500,000 Armistice Capital, LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 5.1% $27,212,212 2,352,634 Dimensional Fund Advisors LP 30 Sep 2025

As of 30 Sep 2025, 268 institutional investors reported holding 44,941,404 shares of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS). This represents 97% of the company’s total 46,382,189 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 15% 6,833,771 +0.07% 0% $78,998,394
T. Rowe Price Investment Management, Inc. 10% 4,713,494 +18% 0.03% $54,488,000
VANGUARD GROUP INC 7.4% 3,425,214 -23% 0% $39,595,473
ARMISTICE CAPITAL, LLC 5.4% 2,500,000 +23% 0.91% $28,900,000
DIMENSIONAL FUND ADVISORS LP 5.1% 2,352,634 -8.7% 0.01% $27,196,336
BROWN ADVISORY INC 4.8% 2,226,756 +23% 0.03% $25,741,303
STATE STREET CORP 4.1% 1,901,262 -0.85% 0% $21,978,589
D. E. Shaw & Co., Inc. 2.8% 1,299,043 +9% 0.01% $15,016,937
GEODE CAPITAL MANAGEMENT, LLC 2.3% 1,067,524 -0.61% 0% $12,341,359
AQR CAPITAL MANAGEMENT LLC 2% 914,175 +63% 0.01% $10,567,862
MILLENNIUM MANAGEMENT LLC 1.9% 896,242 +312% 0.01% $10,360,558
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.9% 863,950 +30% 0% $9,987,262
MORGAN STANLEY 1.8% 832,497 -3% 0% $9,623,678
CLARK ESTATES INC/NY 1.7% 783,880 +59% 2.1% $9,061,653
Qube Research & Technologies Ltd 1.6% 727,838 +16% 0.01% $8,413,807
AMERIPRISE FINANCIAL INC 1.3% 591,181 +357% 0% $6,834,053
JPMORGAN CHASE & CO 1.2% 577,889 +117% 0% $6,680,397
CITADEL ADVISORS LLC 1.2% 574,104 +195% 0.01% $6,636,642
NORTHERN TRUST CORP 1.1% 492,020 +0.39% 0% $5,687,752
GOLDMAN SACHS GROUP INC 0.98% 453,283 +54% 0% $5,239,952
DIAMOND HILL CAPITAL MANAGEMENT INC 0.94% 434,661 +26% 0.02% $5,024,681
ACADIAN ASSET MANAGEMENT LLC 0.92% 427,157 +63% 0.01% $4,935,000
UBS Group AG 0.83% 384,817 +68% 0% $4,448,484
ExodusPoint Capital Management, LP 0.79% 364,193 -71% 0.06% $4,210,071
Pacer Advisors, Inc. 0.71% 328,805 -31% 0.01% $3,800,986

Institutional Holders of AVANOS MEDICAL, INC. - Common Stock - $0.01 Par Value (AVNS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 127,637 $1,443,084 -$7,759 $11.23 18
2025 Q3 44,941,404 $519,510,585 -$417,911 $11.56 268
2025 Q2 44,711,937 $547,287,477 +$14,185,298 $12.24 279
2025 Q1 43,396,946 $623,274,490 -$6,741,914 $14.33 275
2024 Q4 43,159,764 $687,053,030 -$348,352 $15.92 253
2024 Q3 42,887,071 $1,030,142,636 +$14,845,110 $24.03 257
2024 Q2 42,331,138 $843,184,184 -$19,844,468 $19.92 254
2024 Q1 43,394,488 $863,829,555 -$12,610,070 $19.91 255
2023 Q4 43,936,227 $986,177,329 +$6,301,621 $22.43 261
2023 Q3 43,653,986 $883,886,301 -$24,810,694 $20.22 251
2023 Q2 44,367,274 $1,134,245,375 +$6,577,133 $25.56 267
2023 Q1 43,807,927 $1,302,667,520 +$18,327,231 $29.74 278
2022 Q4 43,474,984 $1,176,504,936 +$5,615,427 $27.06 274
2022 Q3 43,372,951 $944,662,406 -$2,543,596 $21.78 218
2022 Q2 43,323,037 $1,184,314,252 -$13,685,481 $27.34 227
2022 Q1 43,970,678 $1,472,010,622 +$2,331,652 $33.50 252
2021 Q4 43,852,763 $1,519,830,657 +$2,873,575 $34.67 251
2021 Q3 43,701,330 $1,363,473,910 -$25,618,497 $31.20 229
2021 Q2 44,393,122 $1,614,401,834 +$1,417,948 $36.37 239
2021 Q1 44,092,800 $1,928,597,642 -$45,329,737 $43.74 251
2020 Q4 45,157,960 $2,071,803,289 -$25,305,709 $45.88 240
2020 Q3 45,956,879 $1,526,673,060 -$9,601,150 $33.22 230
2020 Q2 46,293,558 $1,360,488,473 +$21,246,989 $29.39 233
2020 Q1 45,529,610 $1,226,168,208 -$38,883,046 $26.93 219
2019 Q4 45,819,566 $1,543,944,370 +$20,782,780 $33.70 247
2019 Q3 45,225,869 $1,694,273,669 -$5,936,111 $37.46 250
2019 Q2 45,322,055 $1,976,386,420 +$18,591,188 $43.61 277
2019 Q1 45,113,689 $1,925,520,203 +$46,047,746 $42.68 296
2018 Q4 43,999,885 $1,970,607,092 -$23,436,579 $44.79 305
2018 Q3 42,817,781 $2,932,605,954 +$2,861,296,937 $68.50 350
2018 Q2 1,040,879 $59,567,007 +$59,548,000 $57.26 34
2018 Q1 332 $15,299 +$599 $46.08 2
2017 Q4 319 $14,732 $46.18 2
2017 Q3 319 $14,364 -$1,254 $45.03 2
2017 Q2 347 $13,630 $39.28 3
2017 Q1 347 $13,217 -$457 $38.08 3
2016 Q4 359 $13,276 -$2,737 $36.98 3
2016 Q3 432 $14,973 -$1,629 $34.66 2
2016 Q2 479 $15,577 -$6,000 $32.52 2
2016 Q1 611 $19,762 $28.73 3